Eastgate Biotech Corp (OTCMKTS:ETBI)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.01. Eastgate Biotech shares last traded at $0.01, with a volume of 443,011 shares traded.
About Eastgate Biotech (OTCMKTS:ETBI)
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes.
Further Reading: Why are percentage gainers important?
Receive News & Ratings for Eastgate Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastgate Biotech and related companies with MarketBeat.com's FREE daily email newsletter.